TP53 mutation is not only more frequent in males compared to females, but X-linked negative regulators of p53 in wild-type TP53 cancers including UBE2A, MAGEA2, and UTP14A show higher expression, and association with reduced survival of male patients. This evidence concerns the gene TP53 and cancer.